Cases 31 - 40 of 639
SMITH v. AUROBINDO PHARMA USA, INC. et al
as 1:2023cv04166
Plaintiff:
ANTOINETTE MARIE SMITH
Defendant:
AUROBINDO PHARMA USA, INC., CAMBER PHARMACEUTICALS, INC., JOHNS DOE 1-11 and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WORTHEN et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04163
Plaintiff:
GARY L. WORTHEN and LOLA E. WORTHEN
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03909
Plaintiff:
KENNETH W. WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BUXTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02933
Plaintiff:
DIXIE B BUXTON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
OWENS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03747
Plaintiff:
ANGELA OWENS
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HAUGHTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03646
Plaintiff:
OCIE MAE HAUGHTON
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, ARROW PHARM (MALTA) LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FANNING v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03540
Plaintiff:
LINDA FANNING
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Newron Pharmaceuticals S.p.A et al v. MSN Laboratories Private Limited et al
as 1:2021cv00843
Defendant:
Aurobindo Pharma USA Inc., Prinston Pharmaceutical, Inc., MSN Laboratories Private Limited and others
Plaintiff:
Newron Pharmaceuticals S.p.A., MDD US Operations, LLC and Zambon S.p.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
DAVISON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03279
Plaintiff:
BRUCE DAVISON
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
